The red marrow has hemopoiesis function.

Since bleomycin A6 is less toxic to hemopoiesis and immune function, this conjugate might be more safer for leukemia chemotherapy.

Clinical usage suggested that as is effective in many fields such as enhancement of immunological function, protection of hemopoiesis, etc.